# TANGO THERAPEUTICS, INC. (TNGX) FY2026 Q2 Statement of Cash Flows

- Company: TANGO THERAPEUTICS, INC. (TNGX)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-11, accession number 0001193125-26-343424
- Page: https://plicit.ai/financials/tngx/fy2026-q2-cash-flow
- Chart image: https://plicit.ai/charts/tngx-fy2026-q2-cash-flow-sankey.png

## Chart details

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Mar 31, 2026**: 159,967,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
- **Operating activities**: negative 38,866,000 US dollars. Net cash used.
- **Net loss**: negative 55,342,000 US dollars
- **Depreciation**: 425,000 US dollars
- **Noncash operating lease expense**: 988,000 US dollars
- **Stock-based compensation**: 16,892,000 US dollars
- **Accretion on marketable securities**: negative 945,000 US dollars
- **Other, net**: negative 18,000 US dollars
- **Prepaid expenses and other current assets**: negative 5,192,000 US dollars
- **Other long-term assets**: negative 19,000 US dollars
- **Accounts payable**: negative 759,000 US dollars
- **Accrued expenses and other liabilities**: 5,901,000 US dollars
- **Operating lease liabilities**: negative 797,000 US dollars
- **Investing activities**: negative 445,973,000 US dollars. Net cash used.
- **Purchase of property and equipment**: 20,000 US dollars
- **Sales and maturities of marketable securities**: 73,102,000 US dollars
- **Purchases of marketable securities**: negative 519,095,000 US dollars
- **Financing activities**: 672,569,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the financing total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Proceeds from at-the-market offerings, net of issuance costs), so Proceeds from issuance of common stock and pre-funded warrants cannot be separated for this quarter. It may combine inflows and outflows.
- **Payment of transaction costs**: negative 95,000 US dollars
- **Proceeds from issuance of common stock under stock plans**: 20,624,000 US dollars
- **Remaining financing cash flows, net (calculated)**: 652,040,000 US dollars
- **Operating adjustment reconciliation**: 63,072,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing displayed reconciliation**: 672,664,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
- **investing gross reconciliation**: 519,095,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **Exchange-rate effect**: 0 US dollars
- **Ending cash on Jun 30, 2026**: 347,697,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
- **Cash sources and uses**: 832,536,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: 187,730,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$55.34M + net operating adjustments $16.48M = operating cash −$38.87M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Cash-flow net income is −$55,342.00 K, derived by subtracting the earlier cumulative period; the income statement reports −$55,341.00 K for the same period. The $1.00 K difference is rounding: the filing reports each amount rounded to the nearest thousand dollars, and the quarter is the difference of two rounded year-to-date amounts. Neither amount has been adjusted.
- Cash-flow net income is −$55,342.00 K, derived by subtracting the earlier cumulative period; the income statement reports −$55,341.00 K for the same period. The $1.00 K difference is rounding: the filing reports each amount rounded to the nearest thousand dollars, and the quarter is the difference of two rounded year-to-date amounts. Neither amount has been adjusted.